Department of Hematology and Central Hematological Laboratory

Inselspital Bern

Hematology includes the diagnosis, treatment, and prevention of benign and malignant diseases of the hematopoietic and lymphatic system, blood coagulation, and thrombosis. The Department covers this entire field, offers comprehensive diagnostics and treatment at the highest level, and is also committed to teaching and research.

To the Inselspital website

Profile

  • Teaching students of medicine, dental medicine, pharmacy, biomedical sciences as well as graduate students at the Graduate School of Cellular and Biomedical Sciences (GCB) of the University of Bern
  • 9 research groups; research focus: investigation of epidemiological and pathophysiological processes as well as diagnosis, prognosis, and therapeutic approaches of blood-related disorders, pathophysiological processes that contribute to inflammation and tumor diseases
  • Clinical Study Management Unit (currently 19 ongoing studies)/ Biobanking
  • Largest clinical cell therapy program in Switzerland

External Partners

Steering committee and Advisory Board of Hereditary TTP Registry (www.ttpregistry.net); University of Oklahoma Health Sciences Center, Norman, OK, US; American Society for Transplantation and Cellular Therapy – Survivorship Special Interest Group, EBMT Chronic Malignancies Working Party (CMWP); DKFZ Heidelberg, Heidelberg, Germany; Hematology, Basel University Hospital, Basel, Switzerland; MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; University Hospital Zurich and ETH Zurich, Zurich, Switzerland; Swiss MDS Registry and Biobank; Silence Therapeutics Silence Therapeutics GmbH, Berlin, Germany & plc, London, UK; University of Ottawa, Ottawa, Canada; Lowy Cancer Research Centre, UNSW Sidney, NSW, Australia; Swiss Personalized Health Network (SPHN); Foundation MPN Research Switzerland (Co-founder); Swiss Mastocytosis SCNM (Co-founder); Memorial Sloan Kettering Cancer Center, New York, USA; NYU Langone Perlmutter Cancer Center, New York, USA; Ajax Therapeutics, Cambridge, MA, USA

Grants

  • SNSF 192635, 189090, 185233, NFP78 4078P0_198255, PCEFP3_181357
  • Swiss Cancer Grant (KFS-5158-08-2020), SAKK Grant 33/18
  • Bernese Cancer League, Jacques und Gloria Gossweiler Stiftung, Fondazione San Salvatore, Stiftung für krebskranke Kinder (Basel); Foundation for the Fight against Cancer
  • 3rd Call for Proposals for Personalized Health and Related Technologies PHRT project #2019-717
  • IIR grant (H16-36165) from Baxalta US Inc., Novartis CINC424BCH01R, CSL Behring AG, Alexion,
  • Unrestricted grant from Silence Therapeutics, Access to Insight Funding (NovoNordisk)